Latest News Percept Sponsors Major Latin American Headache Symposium, Science Behind MiWear to Be Presented by International Experts By Staff Friday, May 26, 2023 12:21 AM LAS VEGAS—Percept Corp. has announced the company’s sponsorship of AMCEMIG 2023, the Asociacion Mexicana de Cefaleas y Migranaa, a high-profile international headache symposium in Latin America organized by the Mexican Association of Headaches and Migraines in collaboration with the International Headache Society (IHS). At the symposium to be held at the Guadalajara Hilton from May 25-27, Percept will, for the first time, feature clinical results and scientific findings relevant to the use of Percept’s Narrow Band Green Light (nbGL) technology in eyewear."This technology has the potential to help patients affected by migraine, photophobia, anxiety and sleep difficulties,“ said world-renowned Harvard migraine researcher Dr. Rami Burstein, Ph.D., who will be presenting at the symposium. MiWear is a breakthrough advancement in color wavelength mitigation based on Percept’s patented Augmented Perception technology. The science behind nbGL, which may have calming, relaxation and other therapeutic benefits, was pioneered by Dr. Burstein who became an advisor to Percept. MiWear regulates the full-color spectrum present in naturally occurring light to allow the user to take in only the narrow green-band wavelength (nbGL), while simultaneously enjoying sufficient lens transmissivity to read fine print or operate a smartphone, tablet or view TV. MiWear represents the first in a family of products that can expand eyewear beyond health into the wellness space. It was introduced in March this year, as VMAIL reported. AMCEMIG 2023 Symposium speakers include prominent neuroscientists and headache experts including Rami Burstein, Ph.D., the John Hedley-Whyte professor of Anesthesia of Harvard Medical School; Cristina Tassorelli, MD, director of the Headache Scientific Center, and the Neurorehabilitation Unit of the IRCCS Foundation C. Mondino; Patricia Pozo-Rosich, MD, head of the Neurology Service of Vall d’Hebron, Headache and Pain group head, Barcelona; Messoud Ashina, MD, professor of Neurology at the University of Copenhagen, Denmark; Andrew Charles, MD, professor of Neurology, director of the Goldberg Migraine Program at UCLA; and Agustin Melo-Carrillo, MD, Ph.D., Department of Anesthesia, Critical Care and Pain Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center. Percept Corporation’s CEO, Scott Lewis, said, "We appreciate the many neurological researchers conducting clinical studies with nbGL which is the science MiWear is based on. We look forward to our launch of MiWear in Mexico and Latin America which, combined with the United States, has over 100 million headache/migraine patients that need help to improve their quality of life." Based in Las Vegas, Percept has staff in the U.S. and Italy, in addition to partners in Europe and Asia. The intellectual property underlying Percept’s technology includes licenses for over 44 U.S., European and Chinese patents.